Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.82

-1.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Dodgy Ticker who wrote (10668)	2/26/2004 9:17:11 PM
From: Biomaven	Read Replies (2) of 52153

On topic! Today's NBIX deal to buy back some of the Indiplon royalty stream from WYE ( Message 19853383 ) again raises the DOVP/NBIX relative valuation issue that was initially raised by J.D. Kelley and then discussed on this thread a while back: Message 18899760 A crucial missing piece is the value of the milestones that NBIX is buying back. Anyone know this number or prepared to make an informed guess? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next